Beijing Konruns Pharmaceutical Co., Ltd.
- Country
- 🇨🇳China
- Ownership
- Public
- Established
- 2003-09-03
- Employees
- 447
- Market Cap
- -
- Website
- http://www.konruns.cn
A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma
- First Posted Date
- 2024-08-21
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT06564272
- Locations
- 🇨🇳
Beijing Children's Hospital Affiliated to Capital Medical University, Beijing, Beijing, China
A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer
- Conditions
- Esophageal Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2024-01-08
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.
- Target Recruit Count
- 490
- Registration Number
- NCT06194734
- Locations
- 🇨🇳
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China
A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease
- First Posted Date
- 2023-08-01
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.
- Target Recruit Count
- 414
- Registration Number
- NCT05970783
- Locations
- 🇨🇳
Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical University, Beijing, Beijing, China
A Study of KC1036 in Patients with Advanced Thymic Tumors
- First Posted Date
- 2023-01-13
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT05683886
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
🇨🇳West China Hospital, Chengdu, Sichuan, China
The Effect of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease
- Conditions
- Chronic Pelvic Pain
- Interventions
- Drug: Jincaopian Tablets low doseOther: PlaceboDrug: Jincaopian Tablets high dose
- First Posted Date
- 2022-07-15
- Last Posted Date
- 2022-07-15
- Lead Sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.
- Target Recruit Count
- 180
- Registration Number
- NCT05460546
- Locations
- 🇨🇳
Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical University, Beijing, Beijing, China
A Food Effect Study of KC1036 in Healthy Subjects
- First Posted Date
- 2022-03-03
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT05265338
- Locations
- 🇨🇳
West China Hospital of Sichuan University, Chengdu, Sichuan, China
To Evaluate KC1036 in the Patients with Advanced Digestive System Tumors
- First Posted Date
- 2022-03-02
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.
- Target Recruit Count
- 133
- Registration Number
- NCT05260385
- Locations
- 🇨🇳
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China
🇨🇳The first affiliated hospital of bengbu medical college, Bengbu, China
🇨🇳Chongqing University Three Gorges Hospital, Chongqing, China
A Study of KC1036 in Patients with Advanced Solid Tumors
- First Posted Date
- 2020-05-14
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.
- Target Recruit Count
- 207
- Registration Number
- NCT04387916
- Locations
- 🇨🇳
ChongQing University Cancer Hospital, ChongQing, Chongqing, China
🇨🇳The First Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China
🇨🇳West China Hospital, Chengdu, Sichuan, China
A Phase 1 Study of CX1003 (Kanitinib) in Patients with Advanced Solid Tumors
- First Posted Date
- 2019-09-18
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.
- Target Recruit Count
- 126
- Registration Number
- NCT04093466
- Locations
- 🇨🇳
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China
Study of CX1106 in Patients With Advanced Head and Neck Squamous Cell Carcinoma
- First Posted Date
- 2019-09-17
- Last Posted Date
- 2020-09-03
- Lead Sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.
- Registration Number
- NCT04093115